[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.163.89. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Critical Situations
April 2000

Effectiveness of Infliximab in the Treatment of Refractory Perineal Cutaneous Crohn Disease

Arch Dermatol. 2000;136(4):459-460. doi:10.1001/archderm.136.4.459

A 47-year-old woman presented with a 19-year history of Crohn disease, complicated by ileocolitis, fistulous tract formation, and multiple cutaneous manifestations, including nonfistulous erosions, ulcerations, and nodules involving her perineum and inner thighs. Her clinical course included several surgical reconstructive procedures, azathioprine therapy (100-300 mg/d orally for over 5 years), and long-term courses of intravenous methylprednisolone and oral prednisone (up to 100 mg/d), ciprofloxacin, and metronidazole. All of these therapeutic interventions failed to achieve complete and prolonged remission of her intestinal and cutaneous disease.

First Page Preview View Large
First page PDF preview
First page PDF preview
×